This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Avian Encephalomyelitis Virus Antigen
Product Overview
BioVenic's Recombinant Avian Encephalomyelitis Virus Antigen is a recombinant antigen produced by E.coli. This antigen has undergone a rigorous purification process. It can be used for ELISA plate coating or for the preparation of enzyme conjugates.
Specifications
Target Information
Avian Encephalomyelitis Virus (AEV) is a non-enveloped, positive-sense, single-stranded RNA hepatovirus belonging to the Picornaviridae family. It causes a highly contagious neurological disease primarily affecting young poultry, characterized by ataxia and rapid muscle tremors ("epidemic tremor"). The virus exhibits tropism for the central nervous system and muscular tissues. The major capsid protein, VP1, contains primary neutralizing epitopes and serves as the critical target for serological diagnostics, recombinant subunit vaccine development, and molecular epidemiological tracing.
Shipping and Storage
This product is shipped with gel ice bags. Store at 0-4°C for no more than 2 weeks, or -20°C or below for long-term storage.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.